Release Date |
|
| Sep 16, 2010 |
Advaxis Chairman/CEO Thomas A. Moore Outlined Strategic Plan at the 2010 Rodman & Renshaw Global Healthcare Conference |
| Sep 8, 2010 |
U.S. Patent and Trademark Office Approves Patent that extends ADXS Technology HER2/neu for use in Listeria and Protein Vaccines |
| Aug 24, 2010 |
European Patent Office Allows Advaxis/U. Penn Modified LLO Patent |
| Aug 20, 2010 |
US Patent & Trademark Office to Allow for New Advaxis Patent |
| Aug 3, 2010 |
ADXS Gets Formal Go-Ahead from India's DCGI to Conduct Phase II Cervical Cancer Trial |
| Jun 23, 2010 |
Advaxis Completes Dosing of Vanguard Patient Group in Phase II Cervical Dysplasia Clinical Trial |
| Jun 3, 2010 |
Advaxis Annual Meeting Recap |
| Jun 2, 2010 |
Advaxis and Department of Homeland Security Agree to Cooperative Research and Development Agreement |
| May 28, 2010 |
Advaxis Doses First Cervical Dysplasia Clinical Trial Patient |
| May 26, 2010 |
**** Important Webcast Link for Noble Conference *** |
| May 25, 2010 |
Advaxis Invites Shareholders to the 2010 Advaxis Annual General Meeting |
| May 25, 2010 |
Advaxis to Present at the Noble Financial Sixth Annual Equity Growth Conference - Ontrack 2010 |
| May 18, 2010 |
Advaxis and the University of Pennsylvania Reach Agreement |
| Apr 30, 2010 |
Advaxisâ Live Listeria Prostate Cancer Vaccine Heads for Clinic |
| Apr 15, 2010 |
Advaxis Initiates Phase II Cervical Dysplasia (CIN) Trial |
| Mar 25, 2010 |
Advaxis to Present at the 6th Annual Spring Growth Stock Conference |
| Mar 22, 2010 |
Advaxis Immunotherapeutic ADXS11-001 Phase 1 Survival Data Extended |
| Mar 18, 2010 |
Advaxis Research in ActA Shows Therapeutic Anti-Cancer Response |
| Mar 17, 2010 |
Advaxis Schedules Annual General Meeting |
| Mar 11, 2010 |
Advaxis Develops Room Temperature Formulation of ADXS11-001 |
